<DOC>
	<DOCNO>NCT00390494</DOCNO>
	<brief_summary>The purpose study determine change symptom health-related quality life patient undergoing treatment fibroid . Results questionnaire compare result obtain patient fibroid order determine score range differentiate two group .</brief_summary>
	<brief_title>Questionnaire Study Assess Quality Life After Treatment Fibroids</brief_title>
	<detailed_description>Uterine fibroid common benign uterine tumor affect approximately 70 % woman United States . Sixty percent 600,000 hysterectomy perform United States annually do uterine fibroid . Hysterectomy definitive treatment fibroid demonstrate effective controlling symptom . However , study compare outcome hysterectomy surgical non-surgical therapy outcomes experience `` normal '' population , i.e . diagnosed fibroid . Similarly , relative effectiveness myomectomy uterine fibroid embolization evaluate context fibroid therapy minimally invasive variation . Fibroid symptom experience patient subjective show correlate fibroid number , size , location , clinical measure fibroid . As symptoms impact primary outcome experience patient , validate questionnaire measure impact need . The Uterine Fibroid Symptom Quality Life Questionnaire ( UFS-QoL ) develop focus group woman leiomyomata . The original item capture key symptom area life impact voice focus group participant . Content validity establish cognitive debriefing woman leiomyomata review expert clinician . The UFS-QoL validated patient population woman leiomyomata well `` normal '' control . Using UFS-Qol primary measure , study provide basis comparison woman uterine fibroid therapy . `` Normal '' score establish patient without fibroid . These data provide basis compare outcome result variety investigational therapy . It also provide insight progression fibroid-related symptom patient establish normal baseline . The objective study : A . To determine change symptom health-related quality life patient undergo hysterectomy , myomectomy , uterine fibroid embolization . B . To compare outcomes intervention normal control group well therapy . C. To validate UFS-QoL questionnaire normal population determine normal score range . D. To validate UFS-QoL questionnaire hysterectomy patient determine `` normal '' score patient without uterus .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Fibroid Treatment Group Premenopausal Between age 35 50 , inclusive Scheduled undergo hysterectomy , myomectomy , uterine fibroid embolization treatment uterine fibroid one participate institution Willing provide write informed consent Able speak read English Normal Control Group ( patient diagnose fibroid ) Premenopausal Between age 35 50 , inclusive Normal gynecologic examination time enrollment regular menstrual cycle time enrollment Willing provide write informed consent Able read speak English Fibroid Treatment Group Currently pregnant Cognitive impairment would interfere complete questionnaire Severe psychiatric comorbidity Comorbid lifethreatening condition life expectancy le 1 year Active duty military healthcare beneficiary Normal Control Group Currently pregnant Presence gynecologicrelated disease ( e.g . endometriosis , pelvic inflammatory disease ) Cognitive impairment would interfere complete questionnaire Severe psychiatric comorbidity Comorbid lifethreatening condition life expectancy le 1 year Active duty military healthcare beneficiary</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Fibroids</keyword>
	<keyword>Leiomyoma</keyword>
	<keyword>Hysterectomy</keyword>
	<keyword>Myomectomy</keyword>
	<keyword>Uterine Fibroid Embolization</keyword>
	<keyword>Questionnaire</keyword>
</DOC>